IDEX Q4 sales rise 4%, beat expectations

Reuters
02/04
IDEX Q4 sales rise 4%, beat expectations

Overview

  • Engineered products firm's Q4 sales rose 4%, beating analyst expectations

  • Adjusted EPS for Q4 increased 3%, beating analyst expectations

  • Company utilized $73 mln for share repurchases in Q4

Outlook

  • IDEX expects full-year 2026 organic sales to rise 1% to 2%

  • Company forecasts 2026 adjusted diluted EPS of $8.15 to $8.35

  • IDEX projects Q1 2026 organic sales to increase about 1% from prior year; sees adjusted diluted EPS of $1.73 to $1.78

Result Drivers

  • HST SEGMENT GROWTH - Order growth in HST segment driven by demand for AI-related projects, including data center power solutions and semiconductor applications

  • OPERATIONAL PRODUCTIVITY - Improved operational productivity and cost containment measures contributed to increased gross margin

  • SEGMENT CHALLENGES - FMT and FSDP segments faced lower volumes, partly offset by positive pricing strategies

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Sales

Beat

$899.10 mln

$882.43 mln (11 Analysts)

Q4 Adjusted EPS

Beat

$2.10

$2.04 (11 Analysts)

Q4 EPS

$1.71

Q4 Adjusted Net Income

Beat

$157.20 mln

$153.06 mln (6 Analysts)

Q4 Adjusted EBITDA

Beat

$240.90 mln

$215.20 mln (2 Analysts)

Q4 Adjusted Gross Margin

43.10%

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy", 7 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the industrial machinery & equipment peer group is "buy"

  • Wall Street's median 12-month price target for IDEX Corp is $201.00, about 0.3% below its February 3 closing price of $201.61

  • The stock recently traded at 24 times the next 12-month earnings vs. a P/E of 21 three months ago

Press Release: ID:nBw4TP6qCa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10